“…Among the many approaches used to target intracellular signaling molecules, the drugs rTM and HCQ inhibit NET formation by inhibiting the TLR pathway ( 95 , 99 ). The inhibition of genes such as IL-33, ST2, IL-36R, P2RX1, PKM2, and complement C3 via gene knockout technology or drugs can reduce NET formation and attenuate IRI ( 50 , 105 , 106 , 118 , 129 ). In addition, the interaction of platelets and mast cells with neutrophils can promote the formation of NETs.…”